<DOC>
	<DOCNO>NCT01129622</DOCNO>
	<brief_summary>This study primary investigation determine usefulness safety short course relatively high dose letrozole ( medication use decrease female hormone estrogen produce locally inside breast menopause ) improve performance breast MRI ( Magnetic Resonance Imaging ) . The inhibition estrogen breast letrozole might help good identify suspicious area breast could assist radiologist distinguish benign breast area cancer tissue . This might help reduce rate call back unnecessary biopsy patient . We expect enroll 20 healthy postmenopausal woman study .</brief_summary>
	<brief_title>Effect Aromatase Inhibitors Breast Magnetic Resonance Imaging ( MRI )</brief_title>
	<detailed_description>A breast MRI perform standard way diagnosis serve baseline . A second MRI perform within month follow administration letrozole 12.5 mg daily three day reduce breast estrogen level anticipation lower breast gadolinium dye uptake .</detailed_description>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Women eligible participate 40 year old menopausal ( menstrual bleeding past 12 month ) History bilateral mastectomy , osteoporosis renal impairment .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Letrozole</keyword>
	<keyword>Breast MRI</keyword>
	<keyword>Postmenopausal woman</keyword>
</DOC>